Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis
- 278 Downloads
The standard therapy for high-grade endometrial cancer is surgery but the therapeutic effects of pelvic and paraaortic lymph node dissection (LND) are poorly investigated. In this study, we retrospectively evaluated overall survival, recurrence rates and recurrence-free survival among patients with high-grade type I and II endometrial carcinoma who underwent LND.
This study included 284 patients who are recorded in the German Tumor Centre Regensburg form 1998 to 2015 and were selected by cancer grading, the absence of secondary tumors, primary surgery including hysterectomy and available follow-up. 244 of the 284 patients in this cohort were unequivocally classified as R0 after resection.
A significantly increased overall survival was observed for systematic LND of 25 or more paraaortic and pelvic lymph nodes versus patients who did not undergo such intervention (p < 0.001) or had elective LND of 1–24 lymph nodes both in univariable (p = 0.016) and multivariable (p = 0.014) analysis. A similar observation was made for recurrence-free survival of patients in the cohort who underwent complete tumor resection (R0). In addition, a reduced cumulative recurrence rate was observed for patients with systematic LND.
Our study provides evidence that the systematic removal of 25 or more pelvic and paraaortic lymph nodes reduces the recurrence rate and that it is beneficial for the long-term overall and recurrence-free survival of patients with high-grade endometrial cancer.
KeywordsEndometrial cancer Lymphadenectomy Outcome Overall survival Recurrence
Compliance with ethical standards
Conflict of interest
Thomas Papathemelis, Sophia Scharl, Karin Kronberger, Michael Gerken, Anton Scharl, Armin Pauer and Monika Klinkhammer-Schalke all declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
- Denschlag D, Ulrich U, Emons G (2010) The diagnosis and treatment of endometrial cancer: progress and controversies. Dtsch Ärzteblatt Int 108(34–35):571–577Google Scholar
- Frost JA, Webster KE, Bryant A, Morrison J (2015) LND for the management of endometrial cancer. Cochrane Database Syst Rev 9(9):CD007585Google Scholar
- International Agency for Research on Cancer (2014) World Cancer Report 2014. World Health Organization. Chapter 5.12. ISBN 978-92-832-0429-9Google Scholar
- Thaker PH, Sood AK (2017) Molecular oncology in gynecologic cancer. In: Lentz GM, Lobo RA, Gershenson DM, Katz VL (eds) Comprehensive gynecology (6th edn), Mosby. ISBN 978-0-323-06986-1Google Scholar
- Tumorzentrum Regensburg. Available from: http://www.tumorzentrum-regensburg.de/. Accessed 10 Oct 2016